The Clorox Company (NYSE:CLX) Shares Bought by Arizona State Retirement System

Arizona State Retirement System grew its holdings in shares of The Clorox Company (NYSE:CLX) by 1.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 34,081 shares of the company’s stock after purchasing an additional 354 shares during the period. Arizona State Retirement System’s holdings in Clorox were worth $4,860,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CLX. American Century Companies Inc. increased its holdings in shares of Clorox by 18.0% during the first quarter. American Century Companies Inc. now owns 8,320 shares of the company’s stock valued at $1,157,000 after purchasing an additional 1,269 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in Clorox by 6.8% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 16,465 shares of the company’s stock worth $2,289,000 after acquiring an additional 1,044 shares during the period. Cibc World Market Inc. grew its holdings in Clorox by 276.6% during the first quarter. Cibc World Market Inc. now owns 9,318 shares of the company’s stock worth $1,295,000 after acquiring an additional 6,844 shares during the period. Dimensional Fund Advisors LP grew its holdings in Clorox by 0.8% during the first quarter. Dimensional Fund Advisors LP now owns 683,818 shares of the company’s stock worth $95,073,000 after acquiring an additional 5,145 shares during the period. Finally, Blair William & Co. IL grew its holdings in Clorox by 81.1% during the first quarter. Blair William & Co. IL now owns 24,525 shares of the company’s stock worth $3,410,000 after acquiring an additional 10,981 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 1.1 %

Shares of Clorox stock opened at $144.36 on Tuesday. The firm has a market cap of $17.92 billion, a price-to-earnings ratio of 229.15, a P/E/G ratio of 2.28 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $178.21. The stock has a 50-day simple moving average of $151.60 and a 200-day simple moving average of $141.16.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the company earned $0.98 EPS. The firm’s revenue was up 16.0% on a year-over-year basis. On average, equities research analysts expect that The Clorox Company will post 5.51 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.33%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s payout ratio is 761.92%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. JPMorgan Chase & Co. lifted their target price on Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a report on Thursday, January 18th. Morgan Stanley reaffirmed an “equal weight” rating and set a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. DA Davidson reiterated a “neutral” rating and issued a $162.00 price target on shares of Clorox in a research report on Monday, February 5th. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target for the company in a research report on Tuesday, March 26th. Finally, UBS Group increased their price target on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, February 2nd. Four analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the stock. According to MarketBeat.com, Clorox presently has a consensus rating of “Hold” and a consensus price target of $148.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.